Two major PE-backed cosmetics businesses went public within days of each other on European exchanges—but that is largely where the similarities end.
CVC Capital Partners-backed German perfume and beauty products retailer Douglas went first, debuting on the Frankfurt Stock Exchange Thursday at €25.50 per share (about $27.55). And on Friday, EQT-owned Swiss skincare manufacturer Galderma made its stock market debut on the SIX Swiss Exchange, with shares priced at 53 Swiss francs apiece (around $61.24).
From there, their fortunes diverged considerably. Douglas’ shares slumped by about 10% during its first day of trading, whereas Galderma’s shot up by about 20% by the end of the first day.
It is folly to get too caught up in the business of comparing different IPOs and obsessing over their day-one performance. After all, these are individual businesses on different stock exchanges with varying characteristics and histories. They are, nonetheless, important market indicators.
Galderma’s strong debut will have raised hopes for a long backlog of PE- and VC-backed companies that a European IPO recovery may finally be arriving. The strong performance of Reddit and Astera Labs in their stock market debuts on the other side of the Atlantic will also have boosted morale.
Douglas’ faltering public-markets intro is an important check on too much optimism. The markets are likely to remain very selective. Nonetheless, we would all like IPOs to come back with a bang, but there will probably be a few whimpers first.
Featured image by Dennis Diatel Photography/Getty Images
Learn about our editorial standards.